Abstract
Objectives
We compared characteristics and mortality of patients from a community population meeting enrollment criteria of the second Multicenter Automatic Defibrillator Implantation Trial (MADIT II) to those of the MADIT II subjects.
Background
MADIT II showed that implantable cardioverter-defibrillators (ICDs) reduce mortality in patients with myocardial infarction (MI) and low left ventricular ejection fraction (LVEF) ≤30%.
Methods
We used the resources of the Marshfield Epidemiologic Study Area (MESA), a well defined geographic region to identify MADIT II-type patients and determined outcomes during a 2-year follow-up period.
Results
Of 1,126 patients who survived an MI, 114 (10.1%) had an LVEF ≤30%, 30 had exclusions leaving 84 patients meeting MADIT II-eligibility with a prevalence of 1.95/1,000. Applied to the US population, there would be about 360,000 MADIT II eligible individuals. MESA patients were older and more likely to be women than their MADIT II counterparts. The cumulative probability of death at 2 years in MESA patients (22.7%) was similar to the MADIT II control group (22%), whereas the sudden cardiac death (SCD) rate was lower in MESA (2.6%) than in MADIT II control patients (12%).
Conclusions
Differences in demographics, clinical characteristics and risk of SCD in community patients could alter the effectiveness and cost-effectiveness of ICD therapy from results reported in clinical trials. Further research is urgently needed to determine if the evidence-base used to formulate practice guidelines should be generalized to all individuals who meet eligibility criteria for ICD therapy.
Similar content being viewed by others
References
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M. et al. (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). Journal of the American College of Cardiology, 48, e247–e346.
McClellan, M. B., & Tunis, S. R. (2005). Medicare coverage of ICDs. New England Journal of Medicine, 352, 222–224.
Califf, R. M., & DeMets, D. L. (2002). Principles from clinical trials relevant to clinical practice: Part I. Circulation, 106, 1015–1021.
Lee, P. Y., Alexander, K. P., Hammill, B. G., Pasquali, S. K., & Peterson, E. D. (2001). Representation of elderly persons and women in published randomized trials of acute coronary syndromes. Journal of the American Medical Association, 286, 708–713.
Anderson, K. P. (2005). Sudden cardiac death unresponsive to implantable defibrillator therapy: An urgent target for clinicians, industry and government. Journal of Interventional Cardiac Electrophysiology, 14, 71–78.
Bigger, J. T. Jr, Whang, W., Rottman, J. N., Kleiger, R. E., Gottlieb, C. D., Namerow, P. B. et al. (1999). Mechanisms of death in the CABG Patch trial: A randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation, 99, 1416–1421.
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S. et al. (2002). Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346, 877–883.
DeStefano, F., Eaker, E. D., Broste, S. K., Nordstrom, D. L., Peissig, P. L., Vierkant, R. A. et al. (1996). Epidemiologic research in an integrated regional medical care system: The Marshfield Epidemiologic Study Area. Journal of Clinical Epidemiology, 49, 643–652.
Greenlee, R. T. (2003). Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA). Clinical Medicine and Research, 1, 273–280.
Greenlee, R. T., & Vidaillet, H. (2005). Recent progress in the epidemiology of atrial fibrillation. Current Opinion in Cardiology, 20, 7–14.
Vidaillet, H., Granada, J. F., Chyou, P. H., Maassen, K., Ortiz, M., Pulido, J. N. et al. (2002). A population-based study of mortality among patients with atrial fibrillation or flutter. American Journal of Medicine, 113, 365–370.
Vidaillet, H., Granada, J. F., Chyou, P. H., Maassen, K., Ortiz, M., Pulido, J. N. et al. (2000). Incidence and predictors of atrial flutter in the general population. Journal of the American College of Cardiology, 36, 2242–2246.
Orejarena, L. A., Vidaillet, H. Jr, DeStefano, F., Nordstrom, D. L., Vierkant, R. A., Smith, P. N. et al. (1998). Paroxysmal supraventricular tachycardia in the general population. Journal of the American College of Cardiology, 31, 150–157.
Greenberg, H., Case, R. B., Moss, A. J., Brown, M. W., Carroll, E. R., & Andrews, M. L. (2004). MADIT-II Investigators. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). Journal of the American College of Cardiology, 43, 1459–1465.
Kaplan, E. L., & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457–481.
Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T. et al. (2006). Heart disease and stroke statistics–2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 113, e85–e151.
Marti Almor, J., Delclos Baulies, M., Delclos Urgell, J., Comin Colet, J., Cladellas Capdevila, M., & Bruguera Cortada, J. (2004). Prevalence and clinical course of patients in Spain with acute myocardial infarction and severely depressed ejection fraction who meet the criteria for automatic defibrillator implantation. Revista EspanÄola de CardiologiÂa, 57, 705–708.
Al-Khatib, S. M., Anstrom, K. J., Eisenstein, E. L., Peterson, E. D., Jollis, J. G., Mark, D. B. et al. (2005). Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Annals of Internal Medicine, 142, 593–600.
Gorgels, A. P., Gijsbers, C., de Vreede-Swagemakers, J., Lousberg, A., & Wellens, H. J. (2003). Out-of-hospital cardiac arrest—the relevance of heart failure. The Maastricht Circulatory Arrest Registry. European Heart Journal, 24, 1204–1209.
Tanno, K., Miyoshi, F., Watanabe, N., Minoura, Y., Kawamura, M., Ryu, S. et al. (2005). MADIT II. The multicenter automatic defibrillator implantation trial. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circulation Journal, 69, 19–22.
Layde, P. M., Broste, S. K., Desbiens, N., Follen, M., Lynn, J., Reding, D. et al. (1996). Generalizability of clinical studies conducted at tertiary care medical centers: A population-based analysis. Journal of Clinical Epidemiology, 49, 835–841.
Zheng, Z. J., Croft, J. B., Giles, W. H., & Mensah, G. A. (2001). Sudden cardiac death in the United States, 1989 to 1998. Circulation, 104, 2158–2163.
He, W., Sengupta, M., Velkoff, V. A., & DeBarros, K. A. (2005). 65+ in the United States: 2005. US Census Bureau – Current Population Reports: Special Reports. Washington DC: US Government Printing Office; 2005. Available at: http://www.census.gov/prod/2006pubs/p23-209.pdf. Accessed February 20, 2007.
Krahn, A. D., Connolly, S. J., Roberts, R. S., Gensst, M., ATMA investigators. (2004). Diminishing proportional risk of sudden death with advancing age: Implications for prevention of sudden death. American Heart Journal, 147, 837–840.
Tandri, H., Griffith, L. S., Tang, T., Nasir, K., Zardkoohi, O., Reddy, C. V. et al. (2006). Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm, 3, 762–768.
Zwanziger, J., Hall, W. J., Dick, A. W., Zhao, H., Mushlin, A. I., Hahn, R. M. et al. (2006). The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. Journal of the American College of Cardiology, 47, 2310–2318.
Owens, D. K., Sanders, G. D., Heidenreich, P. A., McDonald, K. M., & Hlatky, M. A. (2002). Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. American Heart Journal, 144, 440–448.
Vorobiof, G., Goldenberg, I., Moss, A. J., Zareba, W., & McNitt, S. (2006). Effectiveness of the implantable cardioverter defibrillator in blacks versus whites (from MADIT-II). American Journal of Cardiology, 98, 1383–1386.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sharma, P.P., Greenlee, R.T., Anderson, K.P. et al. Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: Relation to the second multicenter automatic defibrillator implantation trial. J Interv Card Electrophysiol 19, 157–164 (2007). https://doi.org/10.1007/s10840-007-9151-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-007-9151-8